Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers

Cancer Research

Volumn 63, Issue 14, 2003, Pages 4174-4180

  Yuan, Jiuhong ^a   Luo, Robert Z ^a   Fujii, Satoshi ^a   Wang, Lin ^a   Hu, Wei ^a   Andreeff, Michael ^a   Pan, Yong ^a   Kadota, Mitsutaka ^b   Oshimura, Mitsuo ^b   Sahin, Aysegul A ^a   Issa, Jean Pierre ^a   Bast Jr , Robert C ^a   Yu, Yinhua ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; LUCIFERASE;

ALLELE; ANIMAL CELL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL STRAIN; CELL STRAIN 293; CELL STRAIN A9; CELL STRAIN SKBR3; CHROMOSOME 1P; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA MODIFICATION; DOWN REGULATION; EMBRYO; FEMALE; GENE ARHI; GENE EXPRESSION; GENE FUNCTION; GENE MAPPING; GENE SILENCING; GENETIC CODE; GENETIC TRANSFECTION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

ALLELES; ANIMALS; AZACITIDINE; BREAST NEOPLASMS; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; PROMOTER REGIONS (GENETICS); RHO GTP-BINDING PROTEINS; TUMOR CELLS, CULTURED;

EID: 0041672342     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Jones, P. A. DNA methylation errors and cancer. Cancer Res., 56: 2463-2467, 1996.
2. Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M., and Issa, J. P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res., 72: 141-196, 1997.
3. Jones, P. A., and Laird, P. W. Cancer epigenetics comes of age. Nat. Genet., 21: 163-167, 1999.
4. Baylin, S. B., and Herman, J. G. DNA hypermethylation in tumorigenesis, epigenetics joins genetics. Trends Genet., 16: 168-174, 2000.
5. Ohtani-Fujita, N., Dryja, T. P., Rapaport, J. M., Fujita, T., Matsumura, S., Ozasa, K., Watanabe, Y., Hayashi, K., Maeda, K., Kinoshita, S., Matsumura, T., Ohnishi, Y., Hotta, Y., Takahashi, R., Kato, M. V., Ishizaki, K., Sasaki, M. S., Horsthemke, B., Minoda, K., and Sakai, T. Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma. Cancer Genet. Cytogenet., 98: 43-49, 1997.
6. Dong, S. M., Kim, H. S., Rha, S. H., and Sidransky, D. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin. Cancer Res., 7: 1982-1986, 2001.
7. Catteau, A., Harris, W, H., Xu, C. F., and Solomon, E. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene, 18: 1957-1965, 1999.
8. Rice, J. C., and Futscher, B. W. Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter. Nucleic Acids Res., 28: 3233-3239, 2000.
9. Yu, Y., Xu, F., Fang, X., Zhao, S., Li, Y., Cuevas, B., Kuo, W. L., Gray, J. W., Siciliano, M., Mills, G., and Bast, R. C., Jr. NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc. Natl. Acad. Sci. USA, 96: 214-219, 1999.
10. Wang, L., Hoque, A., Luo, R. Z., Yuan, J., Lu, Z., Nishmoto, A., Liu, J., Sahin, A. A., Lippman, S. M., Bast, R. C., Jr., and Yu, Y. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer. Clin. Cancer Res., in press, 2003.
11. Bao, J. J., Le, X. F., Wang, R. Y., Yuan, J., Wang, L., Atkinson, E. N., LaPushin, R., Andreeff, M., Fang, B., Yu, Y., and Bast, R. C., Jr. Re-expression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway. Cancer Res., 62: 7264-7272, 2002.
12. Peng, H. Q., Xu, F. J., Pershad, R., Hogg, D., Gray, J. W., Berchuck, A., Bast, R. C., Jr., and Yu, Y. H. ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers. Int. J. Cancer, 86: 690-694, 2000.
13. Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., and Issa, J. P. CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA, 96: 8681-8686, 1999.
14. Song, S. H., Jong, S. H., Choi, H. H., Inoue, H., Tanabe, T., Kim, N. K., and Bang, Y. J. Transcriptional silencing of cyclooxygenase-2 by Hyper-methylation of the 5′ CpG island in human gastric carcinoma cells. Cancer Res., 61: 4628-4635, 2001.
15. Kugoh, H., Mitsuya, K., Meguro, M., Shigenami, K., Schulz, T. C., and Oshimura, M. Mouse A9 cells containing single human chromosomes for analysis of genomic imprinting. DNA Res., 6: 165-172, 1999.
16. Inoue, J., Mitsuya, K., Maegawa, S., Kugoh, H., Kadota, M., Okamura, D., Shinohara, T., Nishihara, S., Takehara, S., Yamauchi, K., Schulz, T. C., and Oshimura, M. Construction of 700 human/mouse A9 monochromosomal hybrids and analysis of imprinted genes on human chromosome 6. J. Hum. Genet., 46: 137-145, 2000.
17. Yoshioka, H., Shirayoshi, Y., and Oshimura, M. A novel in vitro system for analyzing parental allele-specific histone acetylation in genomic imprinting. J. Hum. Genet., 46: 626-632, 2001.
18. Sapienza, C. Genome imprinting and carcinogenesis. Biochim. Biophys. Acta, 1072: 51-61, 1991.
19. Kass, S. U., Landsberger, N., and Wolffe, A. P. DNA methylation directs a time-dependent repression of transcription initiation. Curr. Biol., 7: 157-165, 1997.
20. Luo, R. Z., Peng, H., Xu, F., Bao, J., Pang, Y., Pershad, R., Issa, J. P., Liao, W. S., Bast, R. C., Jr., and Yu, Y. Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI. Biochim. Biophys. Acta, 1519: 216-222, 2001.
21. Brandeis, M., Frank, D., Keshet, I., Siegfried, Z., Mendelsohn, M., Nemes, A., Temper, V., Razin, A., and Cedar, H. Sp1 elements protect a CpG island from de novo methylation. Nature (Lond.), 371: 435-438, 1994.
22. Jones, P. L., and Wolffe, A. P. Relationships between chromatin organization and DNA methylation in determining gene expression. Semin. Cancer Biol., 9: 339-347, 1999.
23. Maegawa, S., Yoshioka, H., Itaba, N., Kubota, N., Nishihara, S., Shirayoshi, Y., Nanba, E., and Oshimura, M. Epigenetic silencing of PEG3 gene expression in human glioma cell lines. Mol. Carcinog., 31: 1-9, 2001.
24. Jones, P. A., and Takai, D. The role of DNA methylation in mammalian epigenetics. Science (Wash. DC), 293: 1068-1070, 2001.
25. Nguyen, C., Liang, G., Nguyen, T. T., Tsao-Wei, D., Groshen, S., Lubbert, M., Zhou, J. H., Benedict, W. F., and Jones, P. A. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. J. Natl. Cancer Inst. (Bethesda), 93: 1465-1472, 2001.
26. Steenman, M. J., Rainier, S., Dobry, C. J., Grundy, P., Horon, I. L., and Feinberg, A. P. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumor. Nat. Genet., 7: 433-439, 1994.
27. Pedersen, I. S., Dervan, P. A., Broderick, D., Harrison, M., Miller, N., Delany, E., O'Shea, D., Costello, P., McGoldrick, A., Keating, G., Tobin, B., Gorey, T., and McCann, A. Frequent loss of imprinting of PEG1/MEST in invasive breast cancer. Cancer Res., 59: 5449-5451, 1999.
28. Scelfo, R. A., Schwienbacher, C., Veronese, A., Gramantieri, L., Bolondi, L., Querzoli, P., Nenci, I., Calin, G. A., Angioni, A., Barbanti-Brodano, G., and Negrini, M. Loss of methylation at chromosome 11p15.5 is common in human adult tumors. Oncogene, 21: 2564-2572, 2002.